Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Myriam Chentouf"'
Autor:
Maëva Chauvin, Véronique Garambois, Pierre-Emmanuel Colombo, Myriam Chentouf, Laurent Gros, Jean-Paul Brouillet, Bruno Robert, Marta Jarlier, Karen Dumas, Pierre Martineau, Isabelle Navarro-Teulon, David Pépin, Thierry Chardès, André Pèlegrin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract In ovarian carcinoma, anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets. Here, AMH dose-dependent effect on signaling and proliferation was analyzed in four ovarian
Externí odkaz:
https://doaj.org/article/3bb1d01d694a4347845bf86dc683698e
Autor:
Myriam Chentouf, Caroline Guzman, Moustafa Hamze, René Gross, Anne Dominique Lajoix, Sylvie Peraldi-Roux
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102889 (2014)
We recently reported that pancreatic islets from pre-diabetic rats undergo an inflammatory process in which IL-1β takes part and controls β-cell function. In the present study, using the INS-1 rat pancreatic β-cell line, we investigated the potent
Externí odkaz:
https://doaj.org/article/8114cf3fabd049f7a15201294fd07c53
Autor:
Myriam Chentouf, Gregor Dubois, Céline Jahannaut, Françoise Castex, Anne Dominique Lajoix, René Gross, Sylvie Peraldi-Roux
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e22954 (2011)
Inappropriate food intake-related obesity and more importantly, visceral adiposity, are major risk factors for the onset of type 2 diabetes. Evidence is emerging that nutriment-induced β-cell dysfunction could be related to indirect induction of a s
Externí odkaz:
https://doaj.org/article/67eee055517046da81b1c0abd12b9b1b
Autor:
Bruno Robert, Christel Larbouret, André Pèlegrin, Jean-Max Pasquet, Dany Chalbos, Charles Theillet, Nina Radosevic-Robin, Marta Jarlier, Muriel Busson, Imade Aït-Arsa, Audrey Sirvent, Clément Chevalier, Stanislas du Manoir, Myriam Chentouf, Wilhem Leconet
Supplementary Figure 1. AXL, MER and TYRO-3 expression in Triple Negative Breast Cancer (TNBC) cell lines and PDXs by Western blot analysis. Supplementary Figure 2. AXL mRNA expression in a large dataset of breast cancer tumors. Supplementary Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023a6dc180a6d199242c3f56b2350681
https://doi.org/10.1158/1078-0432.22461975
https://doi.org/10.1158/1078-0432.22461975
Autor:
Bruno Robert, Christel Larbouret, André Pèlegrin, Jean-Max Pasquet, Dany Chalbos, Charles Theillet, Nina Radosevic-Robin, Marta Jarlier, Muriel Busson, Imade Aït-Arsa, Audrey Sirvent, Clément Chevalier, Stanislas du Manoir, Myriam Chentouf, Wilhem Leconet
Suppl.Table 1: Analysis of the cellular localization, pathways and gene expression modification of the 100 genes most correlated with AXL expression in 254 basal-like breast cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635155602a6aa74a17415c756f8d5c63
https://doi.org/10.1158/1078-0432.22461969.v1
https://doi.org/10.1158/1078-0432.22461969.v1
Autor:
Bruno Robert, Christel Larbouret, André Pèlegrin, Jean-Max Pasquet, Dany Chalbos, Charles Theillet, Nina Radosevic-Robin, Marta Jarlier, Muriel Busson, Imade Aït-Arsa, Audrey Sirvent, Clément Chevalier, Stanislas du Manoir, Myriam Chentouf, Wilhem Leconet
Purpose: AXL receptor tyrosine kinase has been described as a relevant molecular marker and a key player in invasiveness, especially in triple-negative breast cancer (TNBC).Experimental Design: We evaluate the antitumor efficacy of the anti-AXL monoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab178ad928c1e3fe9b0a52f7ac1582dd
https://doi.org/10.1158/1078-0432.c.6524970.v1
https://doi.org/10.1158/1078-0432.c.6524970.v1
Autor:
Adrien Tassou, Maxime Thouaye, Damien Gilabert, Antoine Jouvenel, Jean-Philippe Leyris, Corinne Sonrier, Lucie Diouloufet, Ilana Mechaly, Sylvie Mallié, Juliette Bertin, Myriam Chentouf, Madeline Neiveyans, Martine Pugnière, Pierre Martineau, Bruno Robert, Xavier Capdevila, Jean Valmier, Cyril Rivat
Publikováno v:
Progress in Neurobiology. 222:102405
Autor:
Adrien Tassou, Maxime Thouaye, Damien Gilabert, Antoine Jouvenel, Jean-Philippe Leyris, Corinne Sonrier, Lucie Diouloufet, Ilana Mechaly, Sylvie Mallié, Myriam Chentouf, Madeline Neiveyans, Martine Pugnière, Pierre Martineau, Bruno Robert, Xavier Capdevila, Jean Valmier, Cyril Rivat
Acute pain events have been associated with persistent pain sensitization of nociceptive pathways increasing the risk of transition from acute to chronic pain. However, it is unclear whether injuryinduced persistent pain sensitization can promote lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8ad714faa248c39d306e759c51a3c2
https://doi.org/10.1101/2021.11.23.469557
https://doi.org/10.1101/2021.11.23.469557
Autor:
Maeva Chauvin, Laurent Gros, Pierre-Emmanuel Colombo, Isabelle Navarro-Teulon, Alain Mangé, Thierry Chardès, Pierre Martineau, André Pèlegrin, David-Paul De Brauwere, Karen Dumas, Myriam Chentouf, Véronique Garambois, Bruno Robert, Marta Jalier
Publikováno v:
SSRN Electronic Journal.
In ovarian carcinoma, anti-Mullerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets. Conversely, the role of the three AMH type I receptors (AMHRI; ALK2, ALK3 and ALK6) needs to be clari
Autor:
Imade Ait-Arsa, Muriel Busson, André Pèlegrin, Christel Larbouret, Nina Radosevic-Robin, Jean-Max Pasquet, Dany Chalbos, Audrey Sirvent, Clément Chevalier, Charles Theillet, Marta Jarlier, Wilhem Leconet, Bruno Robert, Stanislas du Manoir, Myriam Chentouf
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (11), pp.2806-2816. ⟨10.1158/1078-0432.CCR-16-1316⟩
Clinical Cancer Research, 2017, 23 (11), pp.2806-2816. ⟨10.1158/1078-0432.CCR-16-1316⟩
Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (11), pp.2806-2816. ⟨10.1158/1078-0432.CCR-16-1316⟩
Clinical Cancer Research, 2017, 23 (11), pp.2806-2816. ⟨10.1158/1078-0432.CCR-16-1316⟩
Purpose: AXL receptor tyrosine kinase has been described as a relevant molecular marker and a key player in invasiveness, especially in triple-negative breast cancer (TNBC). Experimental Design: We evaluate the antitumor efficacy of the anti-AXL mono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4677bb5d722dde05b901f646ccf824
https://hal.archives-ouvertes.fr/hal-01676378
https://hal.archives-ouvertes.fr/hal-01676378